Functional interplay between p53 and Δ133p53 in adaptive stress response

被引:13
|
作者
Gong, Lu [1 ,2 ]
Pan, Xiao [3 ,4 ]
Abali, Gamze K. [1 ,2 ]
Little, John B. [2 ]
Yuan, Zhi-Min [1 ,2 ]
机构
[1] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA
[2] Harvard TH Chan Sch Publ Hlth, John B Little Ctr Radiat Sci, Boston, MA 02215 USA
[3] Zhejiang Univ, Affiliated Hosp 1, Hangzhou 310006, Peoples R China
[4] Zhejiang Univ, Inst Translat Med, Sch Med, Hangzhou 310006, Peoples R China
来源
CELL DEATH AND DIFFERENTIATION | 2020年 / 27卷 / 05期
关键词
ISOFORM; CELL; CANCER; DELTA-113P53; EXPRESSION; PATHWAYS; SURVIVAL; MOUSE; DEATH; GENE;
D O I
10.1038/s41418-019-0445-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apart from its well-known prodeath activity, p53 is also implicated in promoting cell survival. How p53 can mediate such seemingly opposing effects is largely unclear. We report here a novel mechanism in which p53-mediated proapoptosis is switched to antiapoptosis via its interaction with a p53 isoform, Delta 133p53. We show that the expression of Delta 133p53 is induced by mild or a moderate level of stress via an HIF1-dependent mechanism. Increased Delta 133p53 levels contribute to the adaptive response by shifting the p53 binding at the Bcl2 promoter from suppressive responsive elements (RE) to activating REs, resulting in induction of Bcl2. In accordance with this mode of action, pretreatment of mice with mild stress induces Delta 133p53 and Bcl2, which is associated with protection of animals from toxicity caused by high doses of DNA damage agents. Collectively, our work uncovers a novel functional interplay between p53 and Delta 133p53 determining cell fate; survival or death in response to stress.
引用
收藏
页码:1618 / 1632
页数:15
相关论文
共 50 条
  • [21] Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
    G Hofstetter
    A Berger
    E Schuster
    A Wolf
    G Hager
    I Vergote
    I Cadron
    J Sehouli
    E I Braicu
    S Mahner
    P Speiser
    C Marth
    A G Zeimet
    H Ulmer
    R Zeillinger
    N Concin
    British Journal of Cancer, 2011, 105 : 1593 - 1599
  • [22] Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
    Hofstetter, G.
    Berger, A.
    Schuster, E.
    Wolf, A.
    Hager, G.
    Vergote, I.
    Cadron, I.
    Sehouli, J.
    Braicu, E. I.
    Mahner, S.
    Speiser, P.
    Marth, C.
    Zeimet, A. G.
    Ulmer, H.
    Zeillinger, R.
    Concin, N.
    BRITISH JOURNAL OF CANCER, 2011, 105 (10) : 1593 - 1599
  • [23] Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development
    Kazantseva, Marina
    Eiholzer, Ramona A.
    Mehta, Sunali
    Taha, Ahmad
    Bowie, Sara
    Roth, Imogen
    Zhou, Jean
    Joruiz, Sebastien M.
    Royds, Janice A.
    Hung, Noelyn A.
    Slatter, Tania L.
    Braithwaite, Antony W.
    JOURNAL OF PATHOLOGY, 2018, 246 (01): : 77 - 88
  • [24] Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant
    Slatter, T. L.
    Hung, N.
    Bowie, S.
    Campbell, H.
    Rubio, C.
    Speidel, D.
    Wilson, M.
    Baird, M.
    Royds, J. A.
    Braithwaite, A. W.
    CELL DEATH & DISEASE, 2015, 6 : e1783 - e1783
  • [25] Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant
    T L Slatter
    N Hung
    S Bowie
    H Campbell
    C Rubio
    D Speidel
    M Wilson
    M Baird
    J A Royds
    A W Braithwaite
    Cell Death & Disease, 2015, 6 : e1783 - e1783
  • [26] Conformational stability and dynamics of the cancer-associated isoform 133p53 are modulated by p53 peptides and p53-specific DNA
    Lei, Jiangtao
    Qi, Ruxi
    Tang, Yegen
    Wang, Wenning
    Wei, Guanghong
    Nussinov, Ruth
    Ma, Buyong
    FASEB JOURNAL, 2019, 33 (03): : 4225 - 4235
  • [27] Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α
    Roselle, Christopher
    Horikawa, Izumi
    Chen, Linhui
    Kelly, Andre R.
    Gonzales, Donna
    Da, Tong
    Wellhausen, Nils
    Rommel, Philipp C.
    Baker, Daniel
    Suhoski, Megan
    Scholler, John
    O'Connor, Roddy S.
    Young, Regina M.
    Harris, Curtis C.
    June, Carl H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (10)
  • [28] A functional interplay between Δ133p53 and ΔNp63 in promoting glycolytic metabolism to fuel cancer cell proliferation
    Lu Gong
    Xiao Pan
    Chuan-Bian Lim
    Anna de Polo
    John B. Little
    Zhi-Min Yuan
    Oncogene, 2018, 37 : 2150 - 2164
  • [29] A functional interplay between Δ133p53 and ΔNp63 in promoting glycolytic metabolism to fuel cancer cell proliferation
    Gong, Lu
    Pan, Xiao
    Lim, Chuan-Bian
    de Polo, Anna
    Little, John B.
    Yuan, Zhi-Min
    ONCOGENE, 2018, 37 (16) : 2150 - 2164
  • [30] p53 regulates the transcription of its Δ133p53 isoform through specific response elements contained within the TP53 P2 internal promoter
    V Marcel
    V Vijayakumar
    L Fernández-Cuesta
    H Hafsi
    C Sagne
    A Hautefeuille
    M Olivier
    P Hainaut
    Oncogene, 2010, 29 : 2691 - 2700